Glenview Trust Co Invests $438,000 in Agilent Technologies, Inc. $A

Glenview Trust Co acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 3,296 shares of the medical research company’s stock, valued at approximately $438,000.

Several other hedge funds have also recently made changes to their positions in A. Core Wealth Advisors LLC bought a new stake in Agilent Technologies in the fourth quarter worth $26,000. SHP Wealth Management bought a new stake in shares of Agilent Technologies in the 4th quarter worth about $26,000. Navalign LLC purchased a new stake in Agilent Technologies in the 4th quarter worth about $27,000. Cedar Mountain Advisors LLC purchased a new stake in Agilent Technologies in the 1st quarter worth about $27,000. Finally, MV Capital Management Inc. purchased a new position in shares of Agilent Technologies during the fourth quarter valued at approximately $28,000.

Key Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

Agilent Technologies Stock Performance

Shares of A stock opened at $154.47 on Friday. The firm has a market cap of $43.63 billion, a price-to-earnings ratio of 30.41, a PEG ratio of 2.65 and a beta of 1.25. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $163.75. The company has a quick ratio of 1.62, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. The company’s 50 day moving average is $140.30 and its 200 day moving average is $127.04.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. The business had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The business’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same quarter last year, the firm earned $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, sell-side analysts anticipate that Agilent Technologies, Inc. will post 6.2 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on A. Citigroup upped their price objective on Agilent Technologies from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Thursday. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Sunday, August 2nd. Bank of America boosted their price objective on shares of Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a research report on Thursday. Piper Sandler started coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price on the stock. Finally, Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $170.33.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.